Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure

Author:

Ponikowski Piotr12,Kirwan Bridget‐Anne34,Anker Stefan D.5,Dorobantu Maria6,Drozdz Jarosław7,Fabien Vincent8,Filippatos Gerasimos9,Haboubi Teba8,Keren Andre10,Khintibidze Irakli11,Kragten Hans12,Martinez Felipe A.13,McDonagh Theresa14,Metra Marco15,Milicic Davor16,Nicolau José C.17,Ohlsson Marcus18,Parhomenko Alexander19,Pascual‐Figal Domingo A.20,Ruschitzka Frank21,Sim David22,Skouri Hadi23,Meer Peter24,Jankowska Ewa A.1

Affiliation:

1. Department of Heart DiseasesWrocław Medical University Wrocław Poland

2. Center for Heart Diseases, Military Hospital Wroclaw Poland

3. Department of Clinical ResearchSOCAR Research SA Nyon Switzerland

4. London School of Hygiene and Tropical MedicineUniversity College London London UK

5. Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin Germany

6. Cardiology Department, Emergency Hospital of Bucharest Bucharest Romania

7. Klinika Kardiologii, Uniwersytet Medyczny w Łodzi Lodz Poland

8. Vifor Pharma Opfikon Switzerland

9. Department of Cardiology, Heart Failure UnitNational and Kapodistrian University of Athens Athens Greece

10. Assuta Hashalom Heart InstituteAssuta Hospitals Tel‐Aviv Israel

11. Aleksandre Aladashvili Clinic, LLC Tbilisi Georgia

12. Molenberglaan Heerlen The Netherlands

13. Universidad Nacional de Córdoba, International Society of Cardiovascular Pharmacotherapy Córdoba Argentina

14. King's College Hospital London UK

15. CardiologyUniversity of Brescia and Civil Hospital Brescia Italy

16. University Hospital Centre Zagreb Zagreb Croatia

17. Faculdade de Medicina FMUSPInstituto do Coracao (InCor), Universidade de Sao Paulo Sao Paulo Brazil

18. Department of Nephrology and TransplantationSkane University Hospital Malmoe Malmo Sweden

19. The M.D. Strazhesko Institute of Cardiology Kyiv Ukraine

20. Cardiology Department, Hospital Virgen de la ArrixacaUniversity of Murcia Murcia Spain

21. UniversitätsSpietal Zürich, Klinik für Kardiologie Zürich Switzerland

22. National Heart Centre, Clinical Translational and Research Office Singapore Singapore

23. American University of Beirut, Medical Center Beirut Beirut Lebanon

24. Department of CardiologyUniversity Medical Center Groningen Groningen The Netherlands

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3